Glaxosmithkline Pharmaceuticals Ltd. benchmarking: Perfomance to industry peers

Financial

	Glaxosmithkline Phar	Ipca Laboratories	Ajanta Pharma
Operational Metrics
Pharmaceuticals
Domestic Sales Growth - YoY	7.8 %	8.3 %	7.5 %
R&D as a % of Total Sales	0.07 %	3.12 %	5.0 %
Financials
5 yr Average ROE	40.73 %	13.55 %	21.63 %
5yr average Equity Multiplier	1.9	1.52	1.32
5yr Average Asset Turnover Ratio	0.94	0.76	0.84
5yr Avg Net Profit Margin	24.91 %	11.88 %	19.77 %
Price to Book	25.71	4.96	7.64
P/E	45.96	44.25	33.86
5yr Avg Cash Conversion Cycle	-107.65 Days	54.3 Days	-102.34 Days
Inventory Days	51.6 Days	102.83 Days	55.16 Days
Days Receivable	22.78 Days	72.68 Days	49.8 Days
Days Payable	144.46 Days	111.38 Days	195.69 Days
5yr Average Interest Coverage Ratio	479.64	50.79	108.5
5yr Avg ROCE	44.44 %	17.31 %	27.48 %
5yr Avg Operating Profit Margin	25.23 %	19.8 %	27.65 %
5 yr average Debt to Equity	0.0	0.17	0.0
5yr CAGR Net Profit	20.96 %	-8.34 %	7.08 %
5yr Average Return on Assets	21.84 %	9.41 %	16.51 %
Shareholdings
Promoter Holding	75.0 %	44.72 %	66.25 %
Share Pledged by Promoters	0.0	0.0	15.28 %
Change in Promoter Holding (3 Yrs)	0.0	-1.57 %	-4.23 %
Change in Mutual Fund Holding (3 Yrs)	1.23 %	0.33 %	3.53 %

Business

	Glaxosmithkline Phar	Ipca Laboratories	Ajanta Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 76.0 Vaccines 24.0 API 0 Generics 0 Branded Generics 0 Pharmaceutical products 0	Product Wise Break-Up Vaccines 0 Formulations 33.08 Pharmaceutical products 0 Active Pharmaceutical Ingredient (API) 16.53 Branded Generics 50.39 Pharmaceutical 0	Product Wise Break-Up Vaccines 0 Generics 0 Pharmaceutical 100.0 API 0 Branded Generics 0 Pharmaceutical 0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Dermatology 30.55 Anti-Infective 22.25 Vaccines 12.64 Pain Management 11.96 Hormones 8.91 Vitamins / Minerals / Nutrients 6.47 Respiratory 3.95 Pain 0 Neutraceuticals 0 Urology 0 Cough Preparations 0 Neuro Psychiatry 0 Gastro-Intestinal (GI) Products 0 Anti-Bacterials 0 Anti-Malarials 0 Cardiovasculars & Anti-Diabetics 0 0 Others 3.27	Therapeutic Area Wise Break-Up - Domestic Cardiac Science 17.0 Vaccines 0 Cough and colds 4.0 Anti Malarials 3.0 Central Nervous System (CNS) 3.0 Pain Management 0 Hormones 0 Anti-Infective 0 Respiratory 0 Gastro Intestinal 2.0 Vitamins / Minerals / Nutrients 0 0 Anti-bacterial 5.0 Pain 53.0 Urology 5.0 Neutraceuticals 1.0 Dermatology 6.0 Others 1.0	Therapeutic Area Wise Break-Up - Domestic Cardiovasculars & Anti-Diabetics 0 Vaccines 0 Cough Preparations 0 Anti-Malarials 0 Neuro Psychiatry 0 Pain Management 0 Hormones 0 Anti-Infective 0 Respiratory 0 Gastro-Intestinal (GI) Products 0 Vitamins / Minerals / Nutrients 0 0 Anti-Bacterials 0 Pain 10.0 Urology 0 Neutraceuticals 0 Dermatology 23.0 Others 67.0
Location Wise Break-Up	Location Wise Break-Up India 98.65 Rest of the World 1.35 Asia (Excluding India) 0 Australia 0 CIS 0 USA 0 Africa 0 Europe 0 Asia 0	Location Wise Break-Up Australia 3.2 Asia 0 USA 21.58 CIS 2.91 Asia Pacific 5.18 Europe 15.68 India 44.73 Rest of the World 0 Africa 6.72	Location Wise Break-Up Australia 0 Asia Pacific 23.15 USA 25.69 CIS 0 Asia (Excluding India) 0 Europe 0 India 32.26 Rest of the World 0 Africa 18.89 Others 0.01
Acute vs Chronic	Acute vs Chronic Acute 99.0 Chronic 1.0	-	-

Glaxosmithkline Pharmaceuticals Ltd.

Glaxosmithkline Pharmaceuticals Ltd.

Financial

Business

SIGN UP FOR FREE